aTyr Pharma Inc. | Mutual Funds
Mutual Funds that own aTyr Pharma Inc.
Fidelity Growth Company Fund
2,218,216
7.42%
-12,036
0%
07/31/2018
Fidelity Select Biotechnology Portfolio
970,388
3.25%
0
0.01%
07/31/2018
Vanguard Total Stock Market Index Fund
473,723
1.59%
0
0%
07/31/2018
Fidelity Series Growth Company Fund
398,874
1.34%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
177,445
0.59%
0
0%
07/31/2018
Fidelity Advisor Biotechnology Fund
144,313
0.48%
-1,546
0%
07/31/2018
BlackRock Small Cap Growth Equity Portfolio
126,299
0.42%
-365
0.01%
05/31/2018
Fidelity Advisor Growth Opportunities Fund
124,576
0.42%
0
0%
07/31/2018
Bridgeway Ultra Small Company Market Fund
102,697
0.34%
0
0.02%
12/31/2017
Fidelity Spartan Extended Market Index Fund
94,162
0.32%
0
0%
07/31/2018
| Address |
3545 John Hopkins Court
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.atyrpharma.com |
| Updated |
07/08/2019 |
| aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of innovative therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. |
